Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Cardiology-CTVS
  • Cardiology & CTVS News
  • Serial NT-proBNP...

Serial NT-proBNP measurements improve risk stratification of patients with pre-Heart Failure

Dr.Niharika Harsha BWritten by Dr.Niharika Harsha B Published On 2023-02-20T11:15:37+05:30  |  Updated On 20 Feb 2023 6:27 AM GMT
Serial NT-proBNP measurements improve risk stratification of patients with pre-Heart Failure
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • koo
  • Email

U.S.A: A new study found that serial N-terminal B-type natriuretic peptide (NT-proBNP) measurements helped in risk stratification of patients with pre-Heart Failure. A 6-year change in NT-proBNP has shown a dynamic change in risk for HF events and death among community-dwelling adults without prevalent clinical HF. The study results were published in the journal...

U.S.A: A new study found that serial N-terminal B-type natriuretic peptide (NT-proBNP) measurements helped in risk stratification of patients with pre-Heart Failure. A 6-year change in NT-proBNP has shown a dynamic change in risk for HF events and death among community-dwelling adults without prevalent clinical HF. The study results were published in the journal JAMA Cardiology.  

NT-proBNP is a well-established biomarker in the diagnosis and prognosis of Heart failure. Incident heart failure events were associated with elevated levels of circulating NT-proBNP. As most of the past guidelines stated that patients with higher NT-proBNP levels were classified as pre-HF, researchers conducted a study to evaluate if NT-proBNP level alterations are associated with future cardiovascular risk among middle-aged individuals without prevalent HF and assess changes in modifiable risk factors like the blood pressure, lipids, and BMI, are associated with a change in NT-proBNP. 

Also Read: Empagliflozin promising in hyponatremia induced by Chronic Syndrome of Inappropriate Antidiuresis

Participants enrolled in the Atherosclerosis Risk in Community (ARIC) study from 4 US communities were recruited for the study. Individuals who attended ARIC visit 2 and 4 with 6 years apart and who were having NT-proBNP measurements without any prevalent HF were included in the study. Assays of NT-proBNP were carried out between 2011 and 2013, and analysis was done between July 2021 and October 2022. NT-proBNP change between visits 2 and 4 was the primary exposure variable, modeled as change categories (<125 pg/mL or ≥125 pg/mL) and as percent change. Incident HF hospitalization and all-cause death were the primary outcome measures. Changes in cardiovascular risk factors with consequent changes in NT-proBNP levels were also assessed. 

Key findings: 

  • There were a total of 9776 individuals with a mean [SD] age, of 57.1 [5.7] years at visit 2 and out of which 5523 [56.5%] were women. 
  • There was a high risk of incident HF and mortality risk in participants with NT-proBNP level of 125 pg/mL or higher at both visits when compared with participants with NT-having proBNP level less than 125 pg/mL at both visits. 
  • The risk of HF and death in participants with NT-proBNP levels of 125 pg/mL or higher at visit 2 and less than 125 pg/mL at visit 4 was similar to the group with NT-proBNP levels of less than 125 pg/mL at both visits.
  • The percent change in NT-proBNP was positively associated with HF and death. 
  • Changes in the levels of systolic blood pressure, low-density lipoprotein cholesterol, triglyceride level, body mass index, and estimated glomerular filtration rate were significantly associated with changes in NT-proBNP.  
Also Read: Early-life adversity may affect childhood mental health and cognitive function: Study

Thus, change in NT-proBNP over 6 years was associated with the risk of incident HF and mortality among middle-aged adults without clinical HF. 

Further reading: Jia X, Al Rifai M, Hoogeveen R, et al. Association of Long-term Change in N-Terminal Pro–B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. Published online February 08, 2023. doi: 10.1001/jamacardio.2022.5309




JAMA CardiologyJAMA NetworkHeart Failure
Source : JAMA Cardiology
Dr.Niharika Harsha B
Dr.Niharika Harsha B

    BDS, MDS

    Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X